Related Experiment Video

Updated: Aug 9, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Hepatitis A in Scotland--is it a continuing problem?

G Kudesia1, E A Follett

  • 1Hepatitis Reference Laboratory, Ruchill Hospital, Glasgow.

Scottish Medical Journal
|April 1, 1988
PubMed

Insights

Hepatitis A virus (HAV) antibody prevalence increases with age, with 78% of adults over 40 infected. Acute hepatitis A cases have declined, shifting the peak infection age group.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis A virus (HAV) infection is a significant public health concern.
  • Understanding the seroprevalence of HAV is crucial for assessing population immunity and disease burden.

Purpose of the Study:

  • To determine the prevalence of anti-HAV antibodies in blood donors and children in West Scotland.
  • To analyze age-specific seroprevalence trends of HAV infection.
  • To evaluate changes in the epidemiology of acute hepatitis A cases over time.

Main Methods:

  • Serological testing for anti-HAV antibodies in blood donor samples.
  • Analysis of patient data from a Glasgow hospital for pediatric cases.
  • Retrospective review of acute hepatitis A case records in West Scotland.

Main Results:

  • By age five, 16% of children had anti-HAV; by age 15, prevalence reached 30%.
  • In adults, HAV antibody prevalence increased with age, reaching 78% in individuals over 40 years.
  • Acute hepatitis A cases in West Scotland have decreased since 1983, with the peak infection age shifting from 5-14 years to 25-34 years.

Conclusions:

  • HAV infection demonstrates a clear age-dependent seroprevalence pattern in West Scotland.
  • The decline in acute hepatitis A cases and the shift in the peak age group suggest changes in transmission dynamics or improved public health interventions.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...